Source: Indian Pharma Post

Bayer : Bayer raises 2026 outlook as pharma growth accelerates

While Pharmaceuticals gathered momentum, Crop Science and Consumer Health continued to perform in line with their respective targets despite challenging market conditions

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
William N. Anderson's photo - CEO of Bayer

CEO

William N. Anderson

CEO Approval Rating

58/100

Read more